InterMune jumps six percent after approval of lung disease drug

lungs78.jpg


Silicon Valley biotech firm InterMune climbed over six percent today after reporting that the European Commission approved its drug to treat a deadly lung disease. http://dock-of-bay.blogspot.com/p/silicon-valley-2.html
 
Back
Top